Upstream Bio Ratios (2023-2026) | UPB

Ratios Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) 45.16%-177.65%-258.98%-350.24%-276.15%-967.24%-272.18%-1,148.80%-380.95%
EBT Margin (Quarter) -1,265.54%-11,668.00%-2,352.34%-3,445.88%-8,415.16%-15,091.03%-6,159.54%-8,980.47%-19,512.30%-30,657.19%-5,975.44%
EBIT Margin (Quarter) -1,511.43%-3,184.44%-2,345.78%-3,439.22%-3,112.52%-4,293.31%-5,656.01%-4,732.87%-5,539.39%-6,911.23%-4,218.09%
EBITDA Margin (Quarter) -1,511.43%-3,184.44%-2,345.78%-3,439.22%-3,112.52%-4,293.31%-5,656.01%-4,732.87%-5,539.39%-6,911.23%-4,218.09%
Operating Margin (Quarter) -1,511.43%-3,184.44%-2,345.78%-3,439.22%-3,112.52%-4,293.31%-5,656.01%-4,732.87%-5,539.39%-6,911.23%-4,218.09%
Net Margin (Quarter) -1,006.92%-3,329.78%-2,189.06%-3,835.69%-3,465.07%-3,554.65%-4,818.02%-4,265.31%-4,941.14%-6,356.14%-5,975.44%
FCF Margin (Quarter) -3,580.00%-2,744.06%-1,575.69%-2,300.16%-3,261.01%-7,272.97%-4,187.73%-3,257.39%-4,601.95%-4,627.85%
Efficiency
Assets Average (Quarter) 357.21M468.94M438.35M405.86M372.48M335.91M
Asset Utilization Ratio (Quarter) 0.010.000.010.010.010.01
Leverage & Solvency
Interest Coverage Ratio (Quarter) -0.36-0.54-0.37-4.22-1.12-0.38-0.28-2.05
Times Interest Earned (Quarter) -0.36-0.54-0.37-4.22-1.12-0.38-0.28-2.05
Valuation
Enterprise Value (Quarter) -47.32M-109.81M-31.51M-47.34M-220.66M-470.45M-431.38M-393.58M-372.43M-341.51M-294.58M
Return Ratios
Return on Sales (Quarter) -0.13%-1.17%-0.24%-0.34%-0.84%-1.51%-0.62%-0.90%-1.95%-3.07%-0.60%
Return on Capital Employed (Quarter) -22.44%-20.63%-28.44%-35.67%-44.66%-53.36%
Return on Assets (Quarter) 0.00%0.00%-0.01%-0.01%-0.01%-0.01%